Exosome biomarkers

Exosome biomarkers are molecules associated with extracellular vesicles that are used to investigate their origin, composition and potential biological functions. These markers can include membrane proteins, cytosolic proteins, lipids and nucleic acids located within vesicles or associated with their surface.

What are exosome biomarkers?

Exosomes are extracellular vesicles associated with the endosomal pathway and released by cells into the extracellular environment. Because different extracellular vesicle populations can have overlapping size ranges, particle dimensions alone cannot establish biological identity.

Biomarkers complement physical characterization by providing information about the molecular composition of the particles. Commonly investigated markers in extracellular vesicle research include members of the tetraspanin family such as CD9, CD63 and CD81, together with proteins associated with intracellular trafficking and vesicle biogenesis.

The detection of a single marker, however, should not automatically be considered definitive evidence that a particle is an exosome. Interpretation should be based on multiple complementary measurements and the biological context of the sample.

What are the main exosome biomarkers?

The appropriate markers depend on the cell type, sample source and scientific question. Several proteins are frequently investigated in preparations enriched in small extracellular vesicles.

• CD9: a membrane tetraspanin frequently detected in extracellular vesicle populations.
• CD63: a protein associated with endosomal compartments and commonly investigated in EV studies.
• CD81: a tetraspanin used as a marker in many extracellular vesicle characterization workflows.
• TSG101: a protein related to the ESCRT machinery and frequently evaluated in studies of vesicle biogenesis.
• ALIX: a protein associated with endosomal processes and the formation of intraluminal vesicles.

Researchers may also investigate markers associated with a particular tissue, cell type, disease or biological pathway depending on the objectives of the study.

How are exosome biomarkers analyzed?

Different analytical techniques can be used to detect molecules associated with extracellular vesicles. Western blotting, immunoassays, flow-based methods, fluorescence techniques and molecular biology approaches can provide information about proteins and nucleic acids in EV preparations.

When the objective is to relate fluorescence signals directly to individual particles in suspension, nanoparticle-based analytical approaches can add important information. The ZetaView Evolution combines NTA with fluorescence analysis and tools for investigating nanoparticle subpopulations, allowing particle size and concentration data to be related to specific fluorescent signals.

Biomarkers and extracellular vesicle subpopulations

An extracellular vesicle preparation can contain particles originating from different cellular pathways and with different molecular compositions. Even particles within similar size ranges can display distinct combinations of markers. Subpopulation analysis is therefore important when studying EV heterogeneity.

Fluorescent markers can help determine which particles are associated with specific proteins or molecules of interest. In more advanced workflows, combinations of multiple markers can provide additional information about specific populations within a heterogeneous sample.

Applications of exosome biomarkers

Analysis of biomarkers associated with exosomes and other extracellular vesicles is used across biomedical and biotechnology research.

• Identification and characterization of extracellular vesicle subpopulations.
• Disease biomarker discovery.
• Cancer and tumor communication research.
• Studies of intercellular communication mechanisms.
• Regenerative medicine research.
• Comparison of extracellular vesicle isolation methods.
• Investigation of vesicle-associated proteins and nucleic acids.

Are CD9, CD63 and CD81 specific to exosomes?

No. These tetraspanins are frequently associated with extracellular vesicles, but they are not exclusive markers of exosomes. Their presence should be interpreted together with additional experimental information and the biological context of the sample.

Can an exosome be identified using biomarkers alone?

A single biomarker is generally insufficient to establish vesicle origin. Robust characterization combines molecular information with physical parameters such as particle size, concentration and morphology, together with methods appropriate to the study objective.

Why analyze more than one biomarker?

Using multiple biomarkers can provide a more complete view of sample heterogeneity and reduce interpretations based on a single molecular characteristic. Different marker combinations can also help investigate EV subpopulations associated with specific cells, tissues or biological processes.